Increasing Testing Capacity for COVID-19 with Sherlock CRISPR-Based Diagnostics

Available on-demand.

[Sherlock™ CRISPR SARS CoV-2 Kit is available for purchase only in the USA.]

CRISPR-based diagnostic methods are poised to have a significant impact on global health, and now, with the first FDA-emergency authorized use of CRISPR technology, this impact is being brought directly to the fight against the global COVID-19 pandemic. Join us to learn more about how Sherlock Biosciences has been driving CRISPR innovation and how that mission, with IDT's support, has led to the Sherlock™ CRISPR SARS-CoV-2 kit. Our speakers will provide an overview of SHERLOCK CRISPR technology and how it has been adapted for specific and sensitive detection of SARS-CoV-2 to increase testing capacity.

Join IDT as we host this webinar to learn:

  • how the SHERLOCK CRISPR-based diagnostic tool works
  • about Sherlock™ CRISPR SARS-CoV-2 kit and performance
  • benefits of the Sherlock CRISPR SARS-CoV-2 kit  
  • how the Sherlock CRISPR SARS-CoV-2 kit can help your lab increase testing capacity

Explore our CRISPR genome editing solutions

Overview
Alt-R CRISPR-Cas9 System
Alt-R CRISPR-Cas12a (Cpf1) System
CRISPR nucleases
Genome editing detection

Event information

Date:

June 23-June 24, 2020